Pioneers in Women's Health
The Viramal team
Our team is led by pioneers in the women's health sector who have developed and licensed market-leading products in the fields of fertility and sexual health.
The senior management team is an experienced cohort with a successful track-record in developing and commercialising innovative therapies for biotechnology companies across the US, Europe and Scandinavia.
Our Board comprises veterans and leading advisors from Industry and the FemMedTech sector.
Management Team
and Executive
Board Members
Oliver Bates
Chief executive officer and co-founder
More info- Experienced biotech & pharma executive.
- Private equity and corporate finance background with emerging and entrepreneurial pharmaceutical and technology businesses.
- Broad transaction experience.
Dr Simona Fiore
Chief medical officer
More info- Board Certified OBGYN obtaining a PhD whilst a Medical Research Council Fellow.
- Scientific Coordinator for the ESHRE Task Force.
- An experienced physician, with experience of running European studies for the NIH across Europe.
Stephen Wise
Chief financial officer
More info- Chartered accountant whose clients included an international pharma business.
- Experienced start up and growth company executive.
- Graduate of two leading business schools.
- Previously worked at Bain & Co management consultants particularly in M&A and private equity.
Non-Executive
Board Members
GP Singh
Chair and Non-Executive Director
More info- Experienced global pharma CEO.
- Previous CEO Jubilant Pharma, US President Sun Pharma.
Enda McVeigh
Non-Executive Director
More info- Associate Professor of Reproductive Medicine and Surgery at the University of Oxford.
- Advisor to the UK Parliamentary All Party group on Fertility and a member of the UK National Patient Support Group for Fertility.
- Founder of several University of Oxford 'spin out' companies including one of the largest IVF groups in the UK as well as an immuno-oncology company.
Nick Thorniley
Non-Executive Director
More info- Public company bio-tech chairman, having had a long and well-respected career in the City of London in corporate broking with small to mid-capitalised companies.
Jonathan Synett
Non-Executive Director
More info- Experienced Fund Manager, and Board Representative for the DPTI Fund where he is the Fund Manager.
Claus Frøkjær-Lorendsen
Board Observer
More info- CEO of Copenhagen-based METIS Family Office A/S, representing Investeringsselskabet MFO Private Equity A/S investment on the Viramal Board.
Anne NiederStaetter
Non-Executive Director
More info- Investment banker with over 20 years' experience.
- Partner at Keyhaven Capital with responsibility for originating, executing and monitoring investments in German speaking Europe.